Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing of pre-treatment primary cervical cancer

ABSTRACT: RNA sequencing of pre-treatment primary cervical cancer

PROVIDER: PRJNA636799 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11908726.fastq.gz	Fastqsanger.gz
	SRR11908727.fastq.gz	Fastqsanger.gz
	SRR11908728.fastq.gz	Fastqsanger.gz
	SRR11908729.fastq.gz	Fastqsanger.gz
	SRR11908730.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 68

Similar Datasets

RNA sequencing of 31 pre-treatment, primary cervical cancer samples

Project description:RNA sequencing of 31 pre-treatment, primary cervical cancer samples

| PRJNA1153589 | ENA

RNA sequencing of pre-treatment primary cervical cancer

Project description:Investigate the transcriptomic differences between HPV-positive and HPV-negative primary cervical tumors.

2020-06-03 | GSE151666 | GEO

RNA sequencing of 31 pre-treatment, primary cervical cancer samples

Project description:Investigate the transcriptomic differences between HPV-positive and HPV-negative primary cervical tumors.

2024-09-02 | GSE275914 | GEO

Proteomic alterations in early stage cervical cancer

Project description:Cervical cancer is characterized by a well-defined pre-malignant phase, cervical intraepithelial neoplasia (CIN). Identification of high grade CIN lesions by population-based screening programs and their subsequent treatment has led to a significant reduction of the incidence and mortality of cervical cancer. Cytology-based testing of cervical smears is the most widely used cervical cancer screening method, but is not ideal, as the sensitivity for detection of CIN2 and higher (CIN2+) is only ~55%. Therefore, more sensitive and specific biomarkers for cervical cancer and its precancerous stages are needed.

2018-05-03 | PXD008723 | Pride

miRNA expression profiling in cervical cancer cells following emodin treatment

Project description:Cervical cancer is one of the most common cancers in women worldwide. The role of HPV in cervical cancer is well studied, however, the underlying mechanism promoting cervical tumorigenesis is still not fully understood. Recently, emodin was shown to induce cell cycle arrest, induction of differentiation, downregulation of TGF β signaling pathway and apoptosis in cervical cancer cell lines. Further, recent studies have shown the role of miRNAs in mediating abnormal regulatory mechanisms leading to the pathogenesis of cervical cancer and large scale miRNA profiling studies have examined the use of miRNAs as cervical cancer diagnostic markers. However, to date, there is no study being performed to analyze the changes in miRNAs following emodin treatment to determine whether emodin mediates its effects by regulating the expression of miRNAs. Therefore, the aim of the current study is to perform miRNA profiling in cervical cancer cells following emodin treatment and to analyze the roles of differentially expressed miRNAs in regulating the pathogenesis and treatment of cervical cancer.

2022-06-30 | GSE135699 | GEO

Epigenome analysis of primary cervical cancer and normal

Project description:Epigenome analysis of primary cervical cancer and normal

| PRJNA871279 | ENA

miRNA expression profiling in cervical cancer cells following curcumin treatment

Project description:Cervical cancer is the second most common cancer in women worldwide. In addition to the important role played by HPV, the underlying mechanism promoting cervical tumorigenesis is complex and involves deregulation of key signaling pathways. Recently, role of miRNA mediated abnormal regulatory mechanisms is implicated in the pathogenesis of cervical cancer. Micro RNAs are regulatory, non‐coding RNAs about 21–23 nucleotides in length and effects the expression of a number of genes at the post‐transcriptional level. For the past few decades, role of curcumin in inhibiting the growth of cervical cancer and increasing the chemo and radio- sensistivity has been studied extensively. Interestingly, curcumin was shown to downregulate NF-κB, Wnt/β-catenin, TGF‐β and various other signaling pathways in cervical cancer cells. Although, a number of microarray studies have examined the use of miRNAs as cancer diagnostic markers, the regulation of miRNAs upon treatment with curcumin in cervical cancer cells has not been studied. The current study is aimed to perform miRNA profiling in cervical cancer cells following curcumin treatment and to study the role of miRNAs in regulating the different signaling pathways.

2022-06-30 | GSE134723 | GEO

Transcription profiling of human cervical cancer, 33 primary tumors, 9 cell lines, and 24 normal cervical epithelium

Project description:This study is aimed in identification of gene expression profiles in cervical cancer and the role of specific genes in cervical carcinogenesis. Experiment Overall Design: A total of 66 samples were included in this study, which include 33 primary tumors, 9 cell lines, and 24 normal cervical epithelium.

2008-06-18 | E-GEOD-9750 | biostudies-arrayexpress

Cervical cancer

Project description:Cervical cancer

| PRJNA144107 | ENA

Cervical cancer samples in NIRS

Project description:cervical cancer samples to test radiosensitivity Keywords: comparison between pre-irradiation and mid-irradiation status, correlation to prognosis

2015-03-23 | GSE6213 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data